Berliner Boersenzeitung - US greenlights pig kidney transplant trials

EUR -
AED 4.256956
AFN 73.025715
ALL 95.949476
AMD 436.297619
ANG 2.074964
AOA 1062.93451
ARS 1612.94327
AUD 1.652435
AWG 2.089356
AZN 1.967595
BAM 1.955789
BBD 2.330587
BDT 141.989225
BGN 1.981335
BHD 0.437098
BIF 3425.18131
BMD 1.159144
BND 1.479892
BOB 7.995956
BRL 6.158991
BSD 1.157194
BTN 108.18041
BWP 15.778914
BYN 3.510781
BYR 22719.216032
BZD 2.327287
CAD 1.590438
CDF 2637.051746
CHF 0.913915
CLF 0.027244
CLP 1075.743011
CNY 7.982325
CNH 8.005156
COP 4253.376791
CRC 540.497051
CUC 1.159144
CUP 30.717307
CVE 110.264398
CZK 24.533102
DJF 206.058876
DKK 7.485174
DOP 68.689625
DZD 153.294405
EGP 59.995673
ERN 17.387155
ETB 182.369105
FJD 2.566866
FKP 0.868886
GBP 0.868988
GEL 3.147122
GGP 0.868886
GHS 12.613931
GIP 0.868886
GMD 85.195634
GNF 10142.944655
GTQ 8.863952
GYD 242.098679
HKD 9.082181
HNL 30.628833
HRK 7.547526
HTG 151.809172
HUF 393.825438
IDR 19654.671984
ILS 3.603923
IMP 0.868886
INR 108.971735
IQD 1515.891728
IRR 1524998.397107
ISK 144.047075
JEP 0.868886
JMD 181.799008
JOD 0.821884
JPY 184.582318
KES 149.909182
KGS 101.364683
KHR 4623.974769
KMF 494.9542
KPW 1043.263627
KRW 1744.871088
KWD 0.355359
KYD 0.964295
KZT 556.326964
LAK 24848.864411
LBP 103633.234522
LKR 360.97803
LRD 211.758845
LSL 19.520593
LTL 3.42265
LVL 0.701154
LYD 7.40796
MAD 10.813041
MDL 20.15189
MGA 4824.973672
MKD 61.639664
MMK 2432.829233
MNT 4136.032637
MOP 9.340449
MRU 46.320747
MUR 53.912042
MVR 17.920267
MWK 2006.589051
MXN 20.785187
MYR 4.565818
MZN 74.068653
NAD 19.520593
NGN 1572.088888
NIO 42.579768
NOK 11.082828
NPR 173.089056
NZD 1.98507
OMR 0.445687
PAB 1.157194
PEN 4.000678
PGK 4.994973
PHP 69.722594
PKR 323.078037
PLN 4.286287
PYG 7557.95876
QAR 4.231477
RON 5.101971
RSD 117.449359
RUB 96.003076
RWF 1683.690813
SAR 4.352186
SBD 9.333031
SCR 15.877613
SDG 696.645486
SEK 10.817726
SGD 1.4866
SHP 0.869658
SLE 28.485998
SLL 24306.675843
SOS 661.296392
SRD 43.453394
STD 23991.933773
STN 24.499866
SVC 10.124945
SYP 128.330276
SZL 19.526893
THB 38.14515
TJS 11.114439
TMT 4.068594
TND 3.417581
TOP 2.790939
TRY 51.295008
TTD 7.850957
TWD 37.135139
TZS 3008.583584
UAH 50.692923
UGX 4373.976133
USD 1.159144
UYU 46.629746
UZS 14107.92302
VES 527.051768
VND 30499.388379
VUV 137.76417
WST 3.161925
XAF 655.953421
XAG 0.017051
XAU 0.000258
XCD 3.132643
XCG 2.085489
XDR 0.815796
XOF 655.953421
XPF 119.331742
YER 276.574852
ZAR 19.764849
ZMK 10433.68695
ZMW 22.593877
ZWL 373.24379
  • RBGPF

    -13.5000

    69

    -19.57%

  • NGG

    -3.5400

    81.99

    -4.32%

  • GSK

    -0.5300

    51.84

    -1.02%

  • RIO

    -2.5000

    83.15

    -3.01%

  • BTI

    -1.3500

    57.37

    -2.35%

  • RELX

    -0.4600

    33.36

    -1.38%

  • BCE

    0.0600

    25.79

    +0.23%

  • CMSC

    -0.2000

    22.65

    -0.88%

  • AZN

    -5.3300

    183.6

    -2.9%

  • BP

    -1.0800

    44.78

    -2.41%

  • RYCEF

    -1.2600

    15.34

    -8.21%

  • CMSD

    -0.2420

    22.658

    -1.07%

  • BCC

    -1.5600

    68.3

    -2.28%

  • VOD

    -0.0900

    14.33

    -0.63%

  • JRI

    -0.3900

    11.77

    -3.31%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: Andrew Caballero-Reynolds - AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

(A.Lehmann--BBZ)